Identification of Patients With Locally Advanced Gastric Cancer Who May Benefit From Adjuvant Chemoradiotherapy After D2 dissection: A Propensity Score Matching Analysis

BACKGROUND: One of the most controversial areas in gastrointestinal oncology is the benefit of postoperative chemoradiotherapy (CRT) over chemotherapy (CT) alone after D2 dissection of locally advanced gastric cancer (LAGC). We aimed to identify the LAGC patients who may benefit from adjuvant CRT. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu-Bei, Qi, Wei-Xiang, Chen, Jia-Yi, Xu, Cheng, Cao, Wei-Guo, Cai, Rong, Cao, Lu, Cai, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047641/
https://www.ncbi.nlm.nih.gov/pubmed/33869049
http://dx.doi.org/10.3389/fonc.2021.648978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047641/
https://www.ncbi.nlm.nih.gov/pubmed/33869049
http://dx.doi.org/10.3389/fonc.2021.648978

Ejemplares similares